Literature DB >> 19307693

Effects of aldosterone on coronary function.

Ludovic Benard1, Paul Milliez, Marie-Lory Ambroisine, Smail Messaoudi, Jane-Lise Samuel, Claude Delcayre.   

Abstract

Our understanding of the effects of aldosterone and its mechanisms has increased substantially in recent years, probably because of the importance of the mineralocorticoid receptor (MR) antagonists in several major cardiovascular diseases. Recent clinical studies have confirmed the benefits of MR antagonists in patients with heart failure, left ventricular dysfunction after myocardial infarction, hypertension or diabetic nephropathy. However, it would be a gross oversimplification to conclude that the role of aldosterone is unequivocally negative. Aldosterone is synthesized in the adrenal glands and binds to specific MRs in target epithelial cells. The steroid-receptor complex penetrates the cell nucleus where it modulates gene expression and activates specific aldosterone-induced proteins that control sodium reabsorption. Recent studies have shown that aldosterone also impacts a wide range of non-epithelial tissues such as the heart and blood vessels. Remarkably, aldosterone can also be synthesized in extra-adrenal tissues and it may act in a rapid non-genomic manner.We note the existence of glucocorticoids that exhibit plasma concentrations much higher than those of aldosterone and that are structurally very similar to aldosterone. It is thus possible that glucocorticoids may bind to the aldosterone receptor in some cell types. Diverse experimental models and several strains of transgenic mice have allowed us to better understand the effects of aldosterone on the heart. Specifically, it seems that a slight increase in cardiac aldosterone concentrations induces a decreased coronary reserve in mice by decreasing the BKCa potassium channels associated with coronary smooth muscle cells. Taken together, these experiments indicate that vascular cells are the primary targets of aldosterone in the cardiovascular system. The hormone directly affects NO and EDHF-mediated coronary relaxation. Both mechanisms may contribute to the deleterious cardiovascular effects of MR stimulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19307693     DOI: 10.1016/s1734-1140(09)70007-6

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  3 in total

1.  Heart failure: aldosterone antagonists are underused by clinicians.

Authors:  Jane-Lise Samuel; Claude Delcayre
Journal:  Nat Rev Cardiol       Date:  2010-03       Impact factor: 32.419

Review 2.  Aldosterone and cardiovascular disease: the heart of the matter.

Authors:  B Julie He; Mark E Anderson
Journal:  Trends Endocrinol Metab       Date:  2012-10-03       Impact factor: 12.015

Review 3.  Aldosterone and the heart: still an unresolved issue?

Authors:  Cristiana Catena; GianLuca Colussi; Francesca Nait; Flavia Martinis; Francesca Pezzutto; Leonardo A Sechi
Journal:  Front Endocrinol (Lausanne)       Date:  2014-10-14       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.